publication venue for
- Miconazole Promotes Cooperative Ability of a Mouse Model of Alzheimer Disease.. 25. 2022
- Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors.. 23. 2020
- Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.. 20. 2017
- Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study.. 19. 2016
- Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.. 19. 2016
- Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.. 19. 2015
- Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.. 18. 2015
- Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism.. 18. 2015
- Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature.. 18. 2015
- Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.. 18. 2014
- Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.. 16. 2012
- Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction.. 16. 2012
- A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia.. 15. 2011
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.. 13. 2010
- Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.. 13. 2010
- Polypharmacy: the good, the bad and the ugly.. 17. 2013
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. 2012
- Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. 2007
- Immune dysregulation in major depression: a critical review of existing evidence. 2002
- Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. 2012
- Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? 2012